![Tom Powles(@tompowles1) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1206581214284537856/9PE8of4J_200x200.png)
Tom Powles
@tompowles1
Interested in Urology Cancers, biomarkers and drug development.
ID:1206580727296544769
16-12-2019 14:24:22
1,3K Tweets
10,9K Followers
60 Following
![Yuji Miura(@YujiMiura5) 's Twitter Profile Photo Yuji Miura(@YujiMiura5) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1793783574807851008/DJadgo_z_200x200.jpg)
![Tres Uramigas(@TresUramigas) 's Twitter Profile Photo Tres Uramigas(@TresUramigas) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1796283275624718336/S528Zm_Q_200x200.jpg)
![ESMO Open(@ESMO_Open) 's Twitter Profile Photo ESMO Open(@ESMO_Open) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1751532612001136640/xo3QN1T1_200x200.jpg)
![Oncology Advance(@OncologyAdvance) 's Twitter Profile Photo Oncology Advance(@OncologyAdvance) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/888294722263027712/4fgo7f8y_200x200.jpg)
![Tres Uramigas(@TresUramigas) 's Twitter Profile Photo Tres Uramigas(@TresUramigas) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1796283275624718336/S528Zm_Q_200x200.jpg)
![Shilpa Gupta(@shilpaonc) 's Twitter Profile Photo Shilpa Gupta(@shilpaonc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1439611610092421126/NNouObVs_200x200.jpg)
Felicidades Uromigos Brian Rini, MD Tom Powles
on your expansion Tres Uramigas
Sumanta K. Pal, MD, FASCO Petros Grivas Neeraj Agarwal, MD, FASCO Toni Choueiri, MD
👏👏👇👇
![Uromigos(@Uromigos) 's Twitter Profile Photo Uromigos(@Uromigos) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1417592551524212742/uPFeOUkt_200x200.jpg)
![Karine Tawagi MD(@DrKarineTawagi) 's Twitter Profile Photo Karine Tawagi MD(@DrKarineTawagi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1157363279187992578/TfZCc3bg_200x200.jpg)
![Daniel Heng(@DrDanielHeng) 's Twitter Profile Photo Daniel Heng(@DrDanielHeng) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/749110713134624768/jUA7OIMA_200x200.jpg)
EV302 Enfortumab and Pembro preserved quality of life in metastatic bladder cancer patients. Sl better pain improvement. QOL is so important to our patients and often underestimated by oncologists. Great work Shilpa Gupta Cleveland Clinic OncoAlert #ASCO24
![Daniel Heng (@DrDanielHeng) on Twitter photo 2024-06-03 13:22:05 EV302 Enfortumab and Pembro preserved quality of life in metastatic bladder cancer patients. Sl better pain improvement. QOL is so important to our patients and often underestimated by oncologists. Great work @shilpaonc @ClevelandClinic @OncoAlert #ASCO24 EV302 Enfortumab and Pembro preserved quality of life in metastatic bladder cancer patients. Sl better pain improvement. QOL is so important to our patients and often underestimated by oncologists. Great work @shilpaonc @ClevelandClinic @OncoAlert #ASCO24](https://pbs.twimg.com/media/GPJtpiabYAAVKCh.jpg)
![Uromigos(@Uromigos) 's Twitter Profile Photo Uromigos(@Uromigos) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1417592551524212742/uPFeOUkt_200x200.jpg)
![Uromigos(@Uromigos) 's Twitter Profile Photo Uromigos(@Uromigos) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1417592551524212742/uPFeOUkt_200x200.jpg)
![Uromigos(@Uromigos) 's Twitter Profile Photo Uromigos(@Uromigos) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1417592551524212742/uPFeOUkt_200x200.jpg)
![Tres Uramigas(@TresUramigas) 's Twitter Profile Photo Tres Uramigas(@TresUramigas) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1796283275624718336/S528Zm_Q_200x200.jpg)
![Tres Uramigas(@TresUramigas) 's Twitter Profile Photo Tres Uramigas(@TresUramigas) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1796283275624718336/S528Zm_Q_200x200.jpg)
![Tres Uramigas(@TresUramigas) 's Twitter Profile Photo Tres Uramigas(@TresUramigas) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1796283275624718336/S528Zm_Q_200x200.jpg)
![Tres Uramigas(@TresUramigas) 's Twitter Profile Photo Tres Uramigas(@TresUramigas) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1796283275624718336/S528Zm_Q_200x200.jpg)
![Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1212658619667365889/FXP-OFGP_200x200.png)
![Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1212658619667365889/FXP-OFGP_200x200.png)
Just presented at #ASCO24 by Matteo Lambertini, MD PhD an international, multicenter, hospital-based, retrospective cohort study including pts harboring germline pathogenic variants (PVs) in BRCA1or BRCA2 and diagnosed with stage I-III invasive #BreastCancer at 40 years or younger.
![Annals of Oncology (@Annals_Oncology) on Twitter photo 2024-06-01 21:15:00 Just presented at #ASCO24 by @matteolambe an international, multicenter, hospital-based, retrospective cohort study including pts harboring germline pathogenic variants (PVs) in BRCA1or BRCA2 and diagnosed with stage I-III invasive #BreastCancer at 40 years or younger. Just presented at #ASCO24 by @matteolambe an international, multicenter, hospital-based, retrospective cohort study including pts harboring germline pathogenic variants (PVs) in BRCA1or BRCA2 and diagnosed with stage I-III invasive #BreastCancer at 40 years or younger.](https://pbs.twimg.com/media/GPAdwPIW0AAG8iW.jpg)
![Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1212658619667365889/FXP-OFGP_200x200.png)
![Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1212658619667365889/FXP-OFGP_200x200.png)